SOPHiA GENETICS Stock (NASDAQ:SOPH)


ForecastOwnershipChartTranscripts

Previous Close

$4.80

52W Range

$2.58 - $5.30

50D Avg

$4.49

200D Avg

$3.54

Market Cap

$317.49M

Avg Vol (3M)

$114.76K

Beta

1.11

Div Yield

-

SOPH Company Profile


SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CH

Employees

423

IPO Date

Jul 23, 2021

Website

SOPH Performance


Latest Earnings Call Transcripts


Q3 25Nov 04, 25 | 8:00 AM
Q2 25Aug 05, 25 | 8:00 AM
Q1 25May 10, 25 | 8:00 AM

Peer Comparison


TickerCompany
SLPSimulations Plus, Inc.
NAKAKindly MD, Inc.
ACIUAC Immune S.A.
AGLAgilon Health, Inc.
OPRXOptimizeRx Corporation
NRCNational Research Corporation
ANROAlto Neuroscience, Inc.
LRMRLarimar Therapeutics, Inc.
DHDefinitive Healthcare Corp.
CLLSCellectis S.A.